Last $52.02 USD
Change Today +0.22 / 0.42%
Volume 5.3K
PJC On Other Exchanges
Symbol
Exchange
New York
As of 9:54 AM 01/29/15 All times are local (Market data is delayed by at least 15 minutes).

piper jaffray cos (PJC) Key Developments

Piper Jaffray Companies Presents at The Bond Buyer's National Outlook 2015 Conference, Jan-27-2015 04:00 PM

Piper Jaffray Companies Presents at The Bond Buyer's National Outlook 2015 Conference, Jan-27-2015 04:00 PM. Venue: Metropolitan Club, One East 60th Street, New York, NY 10022-1054, United States. Speakers: Yaffa Rattner, Managing Director.

Piper Jaffray Companies Presents at 7th annual Biotech Showcase Conference 2015, Jan-12-2015 08:20 AM

Piper Jaffray Companies Presents at 7th annual Biotech Showcase Conference 2015, Jan-12-2015 08:20 AM. Venue: Parc 55 Wyndham San, Francisco - Union Square, San Francisco, CA 94102, United States. Speakers: Josh Schimmer, Managing Director and Senior Research Analyst.

Piper Jaffray Companies Presents at Boston Biotech Conferences LLC's The East Meets West CEO conference, Jan-10-2015 03:40 PM

Piper Jaffray Companies Presents at Boston Biotech Conferences LLC's The East Meets West CEO conference, Jan-10-2015 03:40 PM. Venue: Four Seasons Hotel, 757 Market St, San Francisco, CA 94103. Speakers: Christopher P. Collins, Principal of Biotechnology Investment Banking Group.

Piper Jaffray Companies Presents at Boston Biotech NY/NJ CEO Conference, Nov-12-2014 through Nov-13-2014

Piper Jaffray Companies Presents at Boston Biotech NY/NJ CEO Conference, Nov-12-2014 through Nov-13-2014. Venue: Apella, 450 East 29th Street, New York, New York, United States. Presentation Date & Speakers: Nov-13-2014, Christopher P. Collins, Principal of Biotechnology Investment Banking Group, Joshua Schimmer, Ted Tenthoff.

Piper Jaffray Companies Announces Consolidated Unaudited Earnings Results for the Third Quarter and Nine Months Ended September 30, 2014

Piper Jaffray Companies announced consolidated unaudited earnings results for the third quarter and nine months ended September 30, 2014. For the quarter, the company reported net revenues of $159,426,000 compared with $128,314,000 for the same period a year ago. Income from continuing operations before income tax expense was $25,692,000 compared with $12,060,000 for the same period a year ago. Income from continuing operations was $17,096,000 or $0.90 per diluted share compared with $9,174,000 or $0.42 per diluted share for the same period a year ago. Net income applicable to Piper Jaffray Companies' common shareholders was $13,552,000 or $0.90 per diluted share compared with $4,826,000 or $0.33 per diluted share for the same period a year ago. For the quarter, the company reported adjusted net income from continuing operations was $16.9 million, or $1.03 per diluted common share compared to $11.6 million, or $0.72 per diluted common share, in the third quarter of 2013, and $20.5 million, or $1.25 per diluted common share, in the second quarter of 2014. For the third quarter of 2014, adjusted net revenues were $155.9 million, up 25% compared to $125.0 million in the third quarter of 2013 due primarily to higher advisory services revenues. Adjusted net revenues decreased 7% compared to the second quarter of 2014 due to lower equity and debt financing revenues, partially offset by higher advisory services revenues. Adjusted income from continuing operations before adjusted income tax expense was $26.893 million against $17.440 million a year ago. Annualized quarterly return on common shareholders' equity was 10.2% compared with 4.1% for the same period a year ago. Book value per share was $53.26 compared with $49.11 for the same period a year ago. Tangible book value per share was $37.05 compared with $31.56 for the same period a year ago. For the nine months, the company reported net revenues of $497,590,000 compared with $337,619,000 for the same period a year ago. Income from continuing operations before income tax expense was $88,822,000 compared with $33,561,000 for the same period a year ago. Income from continuing  operations was $60,350,000 or $3.12 per diluted share compared with $23,431,000 or $1.29 per diluted share for the same period a year ago. Net income applicable to Piper Jaffray Companies' common shareholders was $46,386,000 or $3.11 per diluted share compared with $16,163,000 or $1.06 per diluted share for the same period a year ago. Adjusted net income from continuing operations was $57.414 million, or $3.52 per diluted common share compared to $43.674 million or $1.71 per diluted common share a year ago. Adjusted net revenues were $484.045 million compared to $333.758 million a year ago. Adjusted income from continuing operations before adjusted income tax expense was $90.071 million against $43.674 million a year ago.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PJC:US $52.02 USD +0.22

PJC Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Cowen Group Inc $4.21 USD -0.01
Greenhill & Co Inc $36.40 USD -1.83
Oppenheimer Holdings Inc $19.91 USD 0.00
United Bank for Africa PLC 3.53 NGN 0.00
Westamerica Bancorporation $41.63 USD -0.41
View Industry Companies
 

Industry Analysis

PJC

Industry Average

Valuation PJC Industry Range
Price/Earnings 11.2x
Price/Sales 1.2x
Price/Book 1.0x
Price/Cash Flow 10.2x
TEV/Sales NM Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PIPER JAFFRAY COS, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.